LGND
Price
$203.52
Change
-$3.37 (-1.63%)
Updated
Nov 25 closing price
Capitalization
4.01B
98 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$35.46
Change
+$0.81 (+2.34%)
Updated
Nov 25 closing price
Capitalization
4.01B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LGND vs VKTX

Header iconLGND vs VKTX Comparison
Open Charts LGND vs VKTXBanner chart's image
Ligand Pharmaceuticals
Price$203.52
Change-$3.37 (-1.63%)
Volume$212.03K
Capitalization4.01B
Viking Therapeutics
Price$35.46
Change+$0.81 (+2.34%)
Volume$2.23M
Capitalization4.01B
LGND vs VKTX Comparison Chart in %
LGND
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LGND vs. VKTX commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a StrongBuy and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (LGND: $203.52 vs. VKTX: $35.46)
Brand notoriety: LGND and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 115% vs. VKTX: 48%
Market capitalization -- LGND: $4.01B vs. VKTX: $4.01B
LGND [@Biotechnology] is valued at $4.01B. VKTX’s [@Biotechnology] market capitalization is $4.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 2 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • LGND’s FA Score: 2 green, 3 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LGND is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • LGND’s TA Score: 3 bullish, 5 bearish.
  • VKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than LGND.

Price Growth

LGND (@Biotechnology) experienced а -1.70% price change this week, while VKTX (@Biotechnology) price change was -6.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.10%. For the same industry, the average monthly price growth was -2.22%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

LGND is expected to report earnings on Mar 04, 2026.

VKTX is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (+1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.01B) and LGND($4.01B) have the same market capitalization . LGND YTD gains are higher at: 89.939 vs. VKTX (-11.879). LGND has higher annual earnings (EBITDA): -45.94M vs. VKTX (-274.4M). VKTX has more cash in the bank: 715M vs. LGND (255M). VKTX has less debt than LGND: VKTX (755K) vs LGND (5.74M). LGND has higher revenues than VKTX: LGND (188M) vs VKTX (0).
LGNDVKTXLGND / VKTX
Capitalization4.01B4.01B100%
EBITDA-45.94M-274.4M17%
Gain YTD89.939-11.879-757%
P/E Ratio89.66N/A-
Revenue188M0-
Total Cash255M715M36%
Total Debt5.74M755K761%
FUNDAMENTALS RATINGS
LGND vs VKTX: Fundamental Ratings
LGND
VKTX
OUTLOOK RATING
1..100
7078
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
2771
SMR RATING
1..100
8992
PRICE GROWTH RATING
1..100
3746
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for LGND (88). This means that VKTX’s stock grew somewhat faster than LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (27) in the Biotechnology industry is somewhat better than the same rating for VKTX (71). This means that LGND’s stock grew somewhat faster than VKTX’s over the last 12 months.

LGND's SMR Rating (89) in the Biotechnology industry is in the same range as VKTX (92). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's Price Growth Rating (37) in the Biotechnology industry is in the same range as VKTX (46). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for VKTX (100). This means that LGND’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LGND
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEYAX39.880.54
+1.37%
Putnam Large Cap Value A
CNWDX19.990.15
+0.76%
Calamos Evolving World Growth C
FCCNX76.12N/A
N/A
Fidelity Advisor Canada C
CIPIX23.96N/A
N/A
Champlain Mid Cap Institutional
CLSUX27.96N/A
N/A
ClearBridge Sustainability Leaders A

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-1.63%
AGIO - LGND
49%
Loosely correlated
+7.30%
AXON - LGND
49%
Loosely correlated
+0.82%
CRSP - LGND
47%
Loosely correlated
+4.53%
ROIV - LGND
46%
Loosely correlated
+2.76%
VRDN - LGND
45%
Loosely correlated
-1.94%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+2.34%
NEVPF - VKTX
45%
Loosely correlated
N/A
SYRE - VKTX
44%
Loosely correlated
+8.27%
GPCR - VKTX
43%
Loosely correlated
-3.24%
IMTX - VKTX
41%
Loosely correlated
+3.49%
RGNX - VKTX
40%
Loosely correlated
+9.98%
More